Cargando…

Cross-Validation of the Taiwan Version of the Moorehead–Ardelt Quality of Life Questionnaire II with WHOQOL and SF-36

BACKGROUND: Obesity has become a major worldwide public health issue. There is a need for tools to measure patient-reported outcomes. The Moorehead–Ardelt Quality of Life Questionnaire II (MA II) contains six items. The objective of this study was to translate the MA II into Chinese and validate it...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chi-Yang, Huang, Chih-Kun, Chang, Yu-Yin, Tai, Chi-Ming, Lin, Jaw-Town, Wang, Jung-Der
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950928/
https://www.ncbi.nlm.nih.gov/pubmed/19255812
http://dx.doi.org/10.1007/s11695-009-9813-y
_version_ 1782187668565655552
author Chang, Chi-Yang
Huang, Chih-Kun
Chang, Yu-Yin
Tai, Chi-Ming
Lin, Jaw-Town
Wang, Jung-Der
author_facet Chang, Chi-Yang
Huang, Chih-Kun
Chang, Yu-Yin
Tai, Chi-Ming
Lin, Jaw-Town
Wang, Jung-Der
author_sort Chang, Chi-Yang
collection PubMed
description BACKGROUND: Obesity has become a major worldwide public health issue. There is a need for tools to measure patient-reported outcomes. The Moorehead–Ardelt Quality of Life Questionnaire II (MA II) contains six items. The objective of this study was to translate the MA II into Chinese and validate it in patients with morbid obesity. METHODS: The MA II was translated into Chinese and back-translated into English by two language specialists to create the Taiwan version, which was validated by correlations with two other generic questionnaires of health-related quality of life (HRQOL), Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36), and World Health Organization Quality of Life (WHOQOL)-BREF Taiwan version. The convergent validity was accomplished by a series of Spearman rank correlations. Reliability of the MA II Taiwan version was determined by internal consistency obtained by Cronbach’s alpha coefficient and test–retest reliability obtained by intraclass correlation coefficient. RESULTS: One hundred subjects with morbid obesity were enrolled to test the MA II Taiwan version convergent validity and internal consistency. Test–retest studies (2 weeks apart) were applied to 30 morbidly obese patients. Satisfactory internal consistency was demonstrated by a Cronbach’s alpha coefficient of 0.79. Good test–retest reliability was shown by intraclass correlations ranging from 0.73 to 0.91. The total sum of MA II scores was significantly correlated with all four domains of the WHOQOL-BREF and two major components of SF-36 (all correlations, p < 0.01; range, 0.44–0.64). All six MA II items showed significant correlations with each other (r = 0.34–0.69, p < 0.01), and the total sum of MA II scores was negatively correlated with body mass index (r  = −0.31, p < 0.01), indicating a one-dimensional questionnaire of HRQOL. CONCLUSIONS: The MA II Taiwan version is an obesity-specific questionnaire for QOL evaluation with satisfactory reliability and validity. It has the advantages of extensive evaluation for HRQOL, cross-cultural application, rapid completion, high response rates, and an advanced scoring system.
format Text
id pubmed-2950928
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-29509282010-10-21 Cross-Validation of the Taiwan Version of the Moorehead–Ardelt Quality of Life Questionnaire II with WHOQOL and SF-36 Chang, Chi-Yang Huang, Chih-Kun Chang, Yu-Yin Tai, Chi-Ming Lin, Jaw-Town Wang, Jung-Der Obes Surg Research Article BACKGROUND: Obesity has become a major worldwide public health issue. There is a need for tools to measure patient-reported outcomes. The Moorehead–Ardelt Quality of Life Questionnaire II (MA II) contains six items. The objective of this study was to translate the MA II into Chinese and validate it in patients with morbid obesity. METHODS: The MA II was translated into Chinese and back-translated into English by two language specialists to create the Taiwan version, which was validated by correlations with two other generic questionnaires of health-related quality of life (HRQOL), Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36), and World Health Organization Quality of Life (WHOQOL)-BREF Taiwan version. The convergent validity was accomplished by a series of Spearman rank correlations. Reliability of the MA II Taiwan version was determined by internal consistency obtained by Cronbach’s alpha coefficient and test–retest reliability obtained by intraclass correlation coefficient. RESULTS: One hundred subjects with morbid obesity were enrolled to test the MA II Taiwan version convergent validity and internal consistency. Test–retest studies (2 weeks apart) were applied to 30 morbidly obese patients. Satisfactory internal consistency was demonstrated by a Cronbach’s alpha coefficient of 0.79. Good test–retest reliability was shown by intraclass correlations ranging from 0.73 to 0.91. The total sum of MA II scores was significantly correlated with all four domains of the WHOQOL-BREF and two major components of SF-36 (all correlations, p < 0.01; range, 0.44–0.64). All six MA II items showed significant correlations with each other (r = 0.34–0.69, p < 0.01), and the total sum of MA II scores was negatively correlated with body mass index (r  = −0.31, p < 0.01), indicating a one-dimensional questionnaire of HRQOL. CONCLUSIONS: The MA II Taiwan version is an obesity-specific questionnaire for QOL evaluation with satisfactory reliability and validity. It has the advantages of extensive evaluation for HRQOL, cross-cultural application, rapid completion, high response rates, and an advanced scoring system. Springer-Verlag 2009-03-03 2010 /pmc/articles/PMC2950928/ /pubmed/19255812 http://dx.doi.org/10.1007/s11695-009-9813-y Text en © The Author(s) 2009 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Research Article
Chang, Chi-Yang
Huang, Chih-Kun
Chang, Yu-Yin
Tai, Chi-Ming
Lin, Jaw-Town
Wang, Jung-Der
Cross-Validation of the Taiwan Version of the Moorehead–Ardelt Quality of Life Questionnaire II with WHOQOL and SF-36
title Cross-Validation of the Taiwan Version of the Moorehead–Ardelt Quality of Life Questionnaire II with WHOQOL and SF-36
title_full Cross-Validation of the Taiwan Version of the Moorehead–Ardelt Quality of Life Questionnaire II with WHOQOL and SF-36
title_fullStr Cross-Validation of the Taiwan Version of the Moorehead–Ardelt Quality of Life Questionnaire II with WHOQOL and SF-36
title_full_unstemmed Cross-Validation of the Taiwan Version of the Moorehead–Ardelt Quality of Life Questionnaire II with WHOQOL and SF-36
title_short Cross-Validation of the Taiwan Version of the Moorehead–Ardelt Quality of Life Questionnaire II with WHOQOL and SF-36
title_sort cross-validation of the taiwan version of the moorehead–ardelt quality of life questionnaire ii with whoqol and sf-36
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950928/
https://www.ncbi.nlm.nih.gov/pubmed/19255812
http://dx.doi.org/10.1007/s11695-009-9813-y
work_keys_str_mv AT changchiyang crossvalidationofthetaiwanversionofthemooreheadardeltqualityoflifequestionnaireiiwithwhoqolandsf36
AT huangchihkun crossvalidationofthetaiwanversionofthemooreheadardeltqualityoflifequestionnaireiiwithwhoqolandsf36
AT changyuyin crossvalidationofthetaiwanversionofthemooreheadardeltqualityoflifequestionnaireiiwithwhoqolandsf36
AT taichiming crossvalidationofthetaiwanversionofthemooreheadardeltqualityoflifequestionnaireiiwithwhoqolandsf36
AT linjawtown crossvalidationofthetaiwanversionofthemooreheadardeltqualityoflifequestionnaireiiwithwhoqolandsf36
AT wangjungder crossvalidationofthetaiwanversionofthemooreheadardeltqualityoflifequestionnaireiiwithwhoqolandsf36